Predicting isolated postchallenge hyperglycaemia: A new approach; Tehran Lipid and Glucose Study (TLGS)

Diabetic Medicine

Volumn 23, Issue 9, 2006, Pages 982-989

  Hosseinpanah, F ^a   Rambod, M ^a   Reza Ghaffari, H R ^a   Azizi, F ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Diagnosis; Glucose tolerance test; Postchallenge hyperglycemia; Prevalence

Indexed keywords

INSULIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; IRAN; ISOLATED POSTCHALLENGE HYPERGLYCEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY CONSTITUTION; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EPIDEMIOLOGIC METHODS; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; IRAN; LIPIDS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 33747458456     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01939.x     Document Type: Article

References (61)

1. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Comparison of diabetes diagnostic categories in the US population according to 1977 American diabetes association and 1980-1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859-1862.
2. Wahl PW, Savage PJ, Psaty BM, Orchard TJ, Robbins JA, Tracy RP. Diabetes in older adults: a comparison of 1997 American Diabetes Association classification of diabetes mellitus with the 1985 World Health Organization classification. Lancet 1998; 352: 1012-1015.
3. Saadat N, Emami H, Salehi P, Azizi F. Comparison of ADA and WHO criteria in detecting glucose disorders in a population based study. Tehran Lipid and Glucose Study. Iranian J Endocrinol Metab 2002; 4: 1-8 (in Farsi).
4. Gomes-Peres FJ, Auguilar-Salinas CA, Lopez-Alvarenga JC, Perez-Juaregui J, Guillen-Pineda LE, Rull JA. Lack of agreement between the World Health Organization category of impaired glucose tolerance, and American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998; 21: 1886-1888.
5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1196.
6. World Health Organization. Diabetes Mellitus: Report of WHO Study Group. Technical Report Ser. no. 727. Geneva: World Health Organization 1985.
7. Finch CF, Zimmet PZ, Alberti KG. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentration? Diabet Med 1990; 7: 603-610.
8. McCance DR, Hanson RL, Charles MA, Jacobsson LTH, Pettitt DJ, Bennett PH et al. Comparison of tests for glycated hemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994; 308: 1323-1328.
9. Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 1997; 20: 785-791.
10. Pomerleau J, McKeigue PM, Chaturvedi N. Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women? Diabetes Care 1999; 22: 430-433.
11. Bando Y, Ushiogi Y, Okafuji K, Toya D, Tanaka N, Fujisawa M. The relationship of fasting plasma glucose value and other variables to 2-h postload plasma glucose in Japanese subjects. Diabetes Care 2001; 24: 1156-1160.
12. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998; 317: 371-375.
13. Barrett-Connor E, Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo Study. Diabetes Care 1998; 21: 1236-1239.
14. Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 1999; 144: 229-235.
15. Kuizon D, Gordon SM, Dolmatch BL. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
16. de Vegt F, Dekker JM, Ruhe HG, Stehouwer CDA, Nijpels G, Bouter LM et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn study. Diabetologia 1999; 42: 926-931.
17. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988; 319: 1500-1506.
18. Meigs J, Nathan D, Wilson P, Cupples A, Singer D. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study. Ann Intern Med 1998; 128: 524-533.
19. Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL. Postchallenge hyperglycemia and mortality in a national sample of U.S. adults. Diabetes Care 2001; 24: 1397-1402.
20. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ. Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia 1999; 42: 1050-1054.
21. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program. Diabetes 1987; 36: 689-692.
22. Hanefeld M, Fischer S, Julius U, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 1996; 39: 1577-1583.
23. The Decode Study Group on behalf of The European Diabetes Epidemiology Group. Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 1999; 22: 1667-1671.
24. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2004; 27: S11-14.
25. Azizi F, Rahmani M, Emami H, Madjid M. Tehran Lipid and Glucose Study. CVD Prevention 2000; 3: 242-247.
26. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metab Clin N Am 2004; 33: 283-303.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preoparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
28. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002; 162: 209-216.
29. de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 2000; 23: 40-44.
30. The DECODE Study Group. European Diabetes Epidemiology Group: Diabetes Epidemiology. Collaborative analysis of diagnostic criteria in Europe: glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617-621.
31. Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet 1999; 354: 622-625.
32. Rodriguez BL, Lau N, Burchfiel CM, Abbott RD, Sharp DS, Yano K et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 1999; 22: 1262-1265.
33. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 1999; 22: 920-924.
34. Gabir M, Hanson RL, Debelea D, Imperatore G, Rousmain J, Bennett PH et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 2000; 23: 1113-1118.
35. Balkau B, Forhan A, Eschwege E. Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia 2002; 45: 1224-1230.
36. Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002; 25: 1845-1850.
37. Stern MP, Fatehi P, Williams K, Haffner SM. Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care 2002; 25: 1851-1856.
38. DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26: 688-696.
39. Andres R. Aging and diabetes. Med Clin North Am 1971; 55: 835-845.
40. Andres R. Aging, diabetes, and obesity: standards of normality. Mt Sinai J Med 1981; 48: 489-495.
41. Jackson RA. Mechanisms of age-related glucose intolerance. Diabetes Care 1990; 13: 9-19.
42. Ferrara A, Wingard DL, Barrett-Corner E, Shan J. Predictors of change in fasting plasma glucose (FPG) and postchallenge plasma glucose (PCPG) levels in older men and women: the Rancho Bernardo Study 1984-1994. Diabetes 1996; 45: 135A (Abstract).
43. Barrett-Connor E. Factors associated with the distribution of fasting plasma glucose in an adult community. Am J Epidemiol 1980; 112: 518-523.
44. Sayetta RB, Murphy RS. Summary of current diabetes-related data from the National Center for Health Statistics. Diabetes Care 1979; 2: 105-119.
45. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Pravent Med 2002; 47: 408-426.
46. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29-37.
47. Azizi F, Ghanbarian A, Madjid M, Rahmani M. Distribution of blood pressure and prevalence of hypertension in Tehran adult population. Tehran Lipid and Glucose Study (TLGS), 1999-2000. J Hum Hypertens 2002; 16: 305-312.
48. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P et al. Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol 2003; 18: 311-319.
49. DeNino WF, Tchernof A, Dionne IJ, Toth MJ, Ades PA, Sites CK et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001; 24: 925-932.
50. Imbeault P, Prins JB, Stolic M, Russell AW, O'Moore-Sullivan T, Despres JP et al. Aging per se does not influence glucose homeostasis: in vivo and in vitro evidence. Diabetes Care 2003; 26: 480-484.
51. Zavaroni I, Bonini L, Gasparini P, Barilli AL, Zuccarelli A, Dall'Aglio E et al. Hyperinsulinemia in a normal population as a predictor of noninsulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 1999; 48: 989-994.
52. Chen JW, Jen SL, Lee WL, Hsu NW, Lin SJ, Ting CT et al. Differential glucose tolerance in dipper and nondipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension. Diabetes Care 1998; 21: 1743-1748.
53. Feldstein CA, Renauld A, Akopian M, Olivieri AO, Garrido D. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives. J Cardiovasc Risk 1998; 5: 25-30.
54. Fujita Y, Kojima H, Hidaka H, Fujimiya M, Kashiwagi A, Kikkawa R. Increased intestinal glucose absorption and postprandial hyperglycemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats. Diabetologia 1998; 41: 1459-1466.
55. O'Donovan DG, Doran S, Feinle-Bisset C, Jones KL, Meyer JH, Wishart JM et al. Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes. J Clin Endocrinol Metab 2004; 89: 3431-3435.
56. Lee ET, Howard BV, Go O, Savage PJ, Fabsitz RR, Robbins DC et al. Prevalence of undiagnosed diabetes in three American Indian populations. A comparison of the 1997 American Diabetes Association diagnostic criteria and the 1985 World Health Organization diagnostic criteria: the Strong Heart Study. Diabetes Care 2000; 23: 181-186.
57. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J. Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study. Diabetes Care 1997; 20: 163-169.
58. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233-240.
59. Resnick HE, Harris MI, Brock DB, Harris TB. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000; 23: 176-180.
60. Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, Nakai Y et al. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia. Diabetes Care 2003; 26: 1211-1215.
61. Li CL, Tsai ST, Chou P. Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment: The Kinmen Study. J Clin Epidemiol 2002; 55: 19-24.